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We sought genetic effects on labour pain by studying healthy women who did not request analgesia 26 
during their first delivery. Extensive sensory and psychometric testing were normal in these women, 27 
except for significantly higher cuff-pressure pain. We found an excess of heterozygotes carrying 28 
the rare allele of SNP rs140124801 in KCNG4. The rare variant KV6.4-Met419 exerts a dominant 29 
negative effect and cannot modulate the voltage-dependence of KV2.1 inactivation because it fails 30 
to traffic to the plasma membrane. In vivo, we observed Kcng4 (KV6.4) expression in 40% of 31 
retrograde labelled mouse uterine sensory neurones, all of which expressed KV2.1, and over 90% 32 
expressed nociceptor genes Trpv1 and Scn10a. In neurones overexpressing KV6.4-Met419, the 33 
voltage-dependence of inactivation for KV2.1 is more depolarised compared to neurones 34 
overexpressing KV6.4. Finally, KV6.4-Met419 overexpressing neurones have a higher action 35 
potential threshold. We conclude KV6.4 can influence human labour pain by modulating the 36 
excitability of uterine nociceptors. 37 
38 
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprint (which wasthis version posted February 19, 2020. . https://doi.org/10.1101/489310doi: bioRxiv preprint 
BioRxiv KCNG4 Labour Pain                                                                           Page 3 of 31 
 
  39 
Introduction 40 
All eutherians (placental mammals) experience contraction of the uterus and discomfort during 41 
parturition. Whilst this discomfort is universal in eutherians, it appears to be most marked in humans 42 
(1). The severity of labour pain is considered a consequence of positive sexual selection in modern 43 
humans (with females seeking the cleverest mate), which has led to the human brain (and head) 44 
being three times the relative size of our nearest primate relatives (2). Despite neoteny (birth of 45 
offspring in a relatively immature state), this imposes a need to deliver a large neonatal head through 46 
the birth canal causing labour pain (3). While labour pain is clearly linked to uterine contractions 47 
and cervical distension, the generation of this visceral signal and the sensory afferents involved are 48 
poorly understood (4). 49 
Although there are well-established ethnic, social and cultural factors that influence the experience 50 
and expression of pain during labour (5), broader genetic effects on labour pain may also exist. For 51 
example, women with the very rare Mendelian disorder Congenital Insensitivity to Pain due to bi-52 
allelic non-functional mutations in SCN9A (OMIM: 243000) do not report labour pain or require 53 
analgesics during labour (6). SCN9A encodes for the voltage-gated sodium channel NaV1.7, 54 
expressed selectively in nociceptive and autonomic neurones, and mutations in SCN9A have well-55 
documented roles in causing extremely painful or painless phenotypes (7). The painlessness 56 
conferred by loss of function SCN9A mutations is clearly maladaptive and can be associated with 57 
severe injury during human parturition (8). 58 
Our aim here was not to discover very rare Mendelian mutations that cause extreme painlessness, 59 
for example, congenital insensitivity to pain. Instead, the genetic analyses employed here are 60 
optimized for investigation of phenotypes that require both an environmental trigger and genetic 61 
predisposition, that will not appear to have a Mendelian inheritance pattern, unless the triggering 62 
event is frequent (9). This approach is suited to the study of labour pain, which may be considered 63 
nociceptive in nature, with parturition serving as visceral stimulus. We sought to identify functional 64 
SNP alleles that are over- or under-represented in a cohort of women who did not request or use 65 
analgesics that were available and offered to them during labour: an observable behavioural 66 
phenotype that is considered highly unusual in hospital maternity units in the United Kingdom, 67 
particularly for the spontaneous delivery of term nulliparous women. Quantitative sensory testing, 68 
performed with our study cohort, suggest a general increase in pain thresholds and tolerance when 69 
compared to controls, but only the increase in cuff-pressure pain threshold survived statistical 70 
significance after adjustment for multiple comparisons. We next assessed the allele frequencies of 71 
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all (genome-wide) protein changing single nucleotide polymorphisms (SNPs) in these women 72 
compared to population frequencies. We found that the voltage-gated potassium channel (KV) 73 
modifier KCNG4 (KV6.4) SNP rs140124801 rare allele c.1255G>A p.(Val419Met) was over-74 
represented. Finally, we demonstrate effects of this rare KV6.4-Met419 variant on sensory neurone 75 
excitability, and hence reveal a mechanism through which uterine nociception, and hence labour 76 
pain, can be attenuated in humans. 77 
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Identifying women who did not require analgesics during labour as 80 
nulliparous parturients: the test cohort 81 
1029 potential cases were identified from 8 maternity units in the United Kingdom over a three-82 
year period. Each potential case was invited to contact researchers, as chronologically ascertained. 83 
383 women responded and were screened via telephone (Figure S1A). Key inclusion criteria were: 84 
healthy Caucasian women who experienced term (beyond 37-week gestation) and spontaneous 85 
vaginal delivery as nulliparous parturients without any use or request for any form of systemic or 86 
regional analgesia (spinal or epidural). We excluded women who had major disease or co-87 
morbidities that are known to influence labour pain or pain in general. 189 women met the full 88 
eligibility criteria (Table S1), returned written consent, and donated either 10 ml of blood (collected 89 
at their local hospital) or 2 ml of saliva sent via post, from which DNA was extracted. 90 
  91 
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Of the women who donated DNA, 39 consented for a subsequent study of psychometrics and 92 
quantitative sensory testing. These women comprised a subset of the genetic discovery cohort for 93 
a case-controlled study (Figure S1B). For the control cohort, we recruited 33 women who were 94 
matched in age at delivery of the firstborn and location of maternity service, but who used 95 
analgesics during labour and delivery of their firstborn (Table S1). There were no significant 96 
differences in the means of new-born weight or head circumference between test and control 97 
cohorts (Table 1). 98 
Cognitive and emotional function is normal in the test cohort  99 
Psychometrics, comprising validated questionnaires and computerized cognitive assessments, were 100 
employed to quantify mood, beliefs and personality traits that can influence pain in experimental 101 
or clinical settings. The questionnaires included were: Hospital Anxiety and Depression Scale 102 
(HADS) (10), Pain Catastrophizing Scale (PCS) (11), Multidimensional Health Locus of Control 103 
Scale (MHLC) (12) and Life Orientation Test-Revised (LOTR) (13). Computerized cognitive 104 
assessments were implemented in CANTAB® (Cambridge Cognition, UK) (14). There were no 105 
significant differences in psychological or cognitive measures between control and test cohorts 106 
(Table S2). 107 
Experimental pain thresholds and tolerance are increased in the test cohort 108 
Next, we quantified sensory detection and pain thresholds to cold, heat and mechanical pressure. 109 
Thermal stimuli were delivered using a skin thermode applied to the forearm. Mechanical pressure 110 
was exerted via compression of upper arm by a sphygmomanometer cuff. There were no significant 111 
differences in the detection thresholds of cold or cuff-pressure in the test and control cohorts to 112 
suggest sensory deficits or impairments pertaining to those stimuli in the test cohort (Table 1, Figure 113 
S2A). Warmth detection thresholds were very slightly but significantly lower in the test cohort 114 
compared to controls (0.54 °C difference) but all individual values fell within established norms 115 
for the general population (15).  116 
The test cohort had increased pain thresholds to heat, cold and cuff-pressure compared to controls 117 
at an unadjusted significance level of P<0.05 (Figure S2A). There was a very striking increase of 118 
over 50 mmHg in the cuff-pressure pain threshold (P = 0.00002, uncorrected; P = 0.00012, Sidak’s 119 
correction) (Table 1), suggesting that this characteristic might be relevant to the lack of analgesic 120 
requirement during nulliparous labour in the test cohort. 121 
During testing for tolerance to pain from the immersion of hand in cold water (3 °C), when 122 
compared to controls, the test cohort showed increased hand withdrawal latency (P = 0.03, 123 
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uncorrected), lower post-immersion skin temperatures (P = 0.02, uncorrected), and lower peak 124 
intensity of pain on the 100 mm Visual Analogue Scale (VAS) (P = 0.004, uncorrected;  P = 0.02, 125 
Sidak’s correction) on later assessment (Figure S2B).  The Short-Form McGill Pain questionnaire 126 
(16) revealed lower scores (P = 0.01, uncorrected; P = 0.049, corrected) for the sensory descriptors 127 
for the test group. There was no between-group difference in scores related to the affective aspects 128 
of the experimentally induced pain experienced (P = 0.26). These individual results do not survive 129 
statistical correction for multiple comparisons but suggest that overall the test cohort of women 130 
who did not request analgesia during nulliparous parturition showed greater tolerance to pain when 131 
compared to controls. 132 
The rare allele of rs140124801 in KCNG4 is over-represented in the test cohort  133 
In 158 of the 189 women who did not require analgesics during their first labour, we obtained 134 
enough high-quality DNA for molecular genetic analysis (Figure S1). The chronologically first 100 135 
such women (by date of banking DNA) constituted a discovery cohort (Figure 1A); the next 58 136 
women constituted our replication cohort. Those in the discovery cohort each had exome 137 
sequencing, from which we used the bam and bam.bai files for genome wide SNP allele frequency 138 
assessment using the fSNPd programme (9). The replication cohort of 58 were assessed only for 139 
SNP rs140124801 alleles using Sanger sequencing of genomic DNA. 140 
Our discovery cohort analysis identified one ion channel SNP where the allele frequency was 141 
altered compared to reference (Figure 1A). The rare allele of rs140124801 in KCNG4 was over-142 
represented, being found in 3 instances, whereas 0.7 instances were expected (q=<0.05, FDR 143 
corrected). We examined the individual exome results using the Integrated Genome Viewer 144 
(https://software.broadinstitute.org/software/igv/) and found that 3 individuals were heterozygous 145 
for the rare allele and confirmed this by Sanger sequencing. In the replication cohort, we found one 146 
further rare SNP rs140124801 heterozygote. For the total cohort of 158 women not requiring 147 
analgesia during their first delivery, there were 4 heterozygotes carrying the rs140124801 rare allele 148 
compared to an expected 1.1 (Chi-squared two tail with Yates correction = 4.779, P = 0.0288; 149 
Figure S1A). 150 
In case-controlled studies, we further explored whether 3 of the individuals who possess the rare 151 
KCNG4 allele had significantly different experimental pain thresholds to those who did not (n=69, 152 
Figure S1B). We investigated pain thresholds for heat, cold and cuff-pressure, and found that the 153 
rare KCNG4 allele was associated with a significantly increased cuff-pressure pain threshold (P = 154 
0.0029, uncorrected; P = 0.009, Sidak’s correction, Table S3). Although the sample size here is 155 
very small because of the rarity of the KCNG4 allele being examined, the finding suggests that an 156 
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effect of this rare-allele is to increase experimental cuff-pressure pain threshold in humans. The 157 
experimental cuff-pressure pain remains significantly increased in the test cohort (even with the 3 158 
rare-allele cases excluded, when compared with the control group (P = 0.0029, uncorrected; P = 159 
0.009, Sidak’s correction, Table S3) suggesting that cuff-pressure pain threshold might be relevant 160 
to the labour pain. Whilst, there are clearly other reasons for increased cuff-pressure pain threshold 161 
in those cases who do not carry the rare KCNG4 allele, these data suggest that the rare-allele of 162 
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The rare allele of rs140124801 in KCNG4 introduces a p.Val419Met change in 167 
the highly conserved K+ selectivity filter consensus sequence  168 
The rare allele of rs140124801 in KCNG4 causes the mis-sense change p.Val419Met encoding the 169 
voltage-gated potassium channel KV6.4 (from here on referred to as KV6.4-Met419; Figure 1A-B). 170 
Voltage-gated potassium channels are tetrameric complexes with each subunit having six 171 
transmembrane domains (S1-S6). KV6.4 is a member of the electrically silent group of KV subunits, 172 
which cannot form functional plasma membrane-expressed homotetramers, but instead act as 173 
modulators of KV2 subunits (17). Indeed, KV6.4 is known to heterotetramerise with KV2.1 in a 1:3 174 
stoichiometry (18). Valine 419 is in the pore forming S5-S6 linker and is part of the highly 175 
conserved K+ selectivity filter consensus sequence (TVGYG) (Figure 1C), in which the equivalent 176 
position is always occupied by a branched chain amino acid. Whilst originally thought to be 177 
relatively rigid, this structure is also involved in open-pore or C-type inactivation, as subtle 178 
rearrangements block the conductive path of K+ ions (19). The molecular mechanisms underlying 179 
KV2.1 channel inactivation remain unclear, but include interference with the predominant U-type 180 
inactivation from closed states (20) by the KV2.1-E352Q mutation (21) or, in the case of 181 
KV6.4/KV2.1 heterotetrameric channels, treatment with 4-aminopyridine (22), unveiled C-type 182 
inactivation. KV6.4/KV2.1 heterotetramers display a hyperpolarizing shift in the voltage-183 
dependence of inactivation compared to the KV2.1 homotetramers, which has been linked to 184 
differences in the voltage sensing S4 segment (23), but additional contributions from the S5-S6 185 
linker have not been excluded. It seemed likely that rs140124801 might affect K+-selectivity and/or 186 
inactivation. We therefore studied the electrophysiological properties of KV6.4-Met419 in complex 187 
with KV2.1 compared to the most frequent KCNG4 allele that possesses a valine at position 419 188 
(KV6.4) in complex with KV2.1. 189 
The p.Val419Met change in KV6.4 impairs function of KV2.1 heterotetramers 190 
We used HEK293 cells as a heterologous expression system that does not express significant 191 
endogenous KV currents (Figure S3). As expected, over-expression of KV6.4 or KV6.4-Met419 192 
alone did not produce measurable K+ currents (Figure S3E). However, in cells expressing KV2.1 193 
alone, outward currents were observed that were activated by potentials more positive than −40 mV 194 
and displayed a slow inactivation (Figure S3A). Co-expression of KV2.1 with KV6.4 produced 195 
outward currents with similar kinetics (Figure S3D), but we observed a small shift in the voltage of 196 
half-maximal activation (V0.5 act) to more negative potentials. This shift was not observed when 197 
KV6.4-Met419 was co-expressed with KV2.1 (Figure S3D). The current amplitude generated was 198 
similar between wild-type KV6.4 or KV6.4-Met419 co-expressed with KV2.1 (Figure S3E) showing 199 
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that expression of KV6.4-Met419 does not negatively regulate maximal current flux, over wild-type 200 
KV6.4, a factor that would impact sensory neurone excitability (Figure S3E). The slope factors of 201 
the Boltzmann fits did not significantly differ between the 3 groups (KV2.1: k = 9.5 ± 0.8, n = 13; 202 
KV2.1 + KV6.4: k = 15.9 ± 1.7, n = 14; KV2.1 + KV6.4-Met419: k = 11.0 ± 0.8, n = 13; one-way 203 
ANOVA, P > 0.05). Furthermore, the reversal potential was not significantly different between the 204 
groups (Figure S3F). 205 
Similar to previous reports (23), co-expression of KV6.4 resulted in a large hyperpolarising shift in 206 
the voltage-dependence of inactivation by ~30 mV compared to KV2.1 homomeric currents (Figure 207 
1D, E & G). This hyperpolarising shift was not observed when KV2.1 was co-expressed with KV6.4-208 
Met419 (Figure 1F & G). There was however no significant difference in the slope factor of 209 
inactivation curves between the three groups  (KV2.1: k = 9.8 ± 1.4, n = 9; KV2.1 + KV6.4: k = 13.6 210 
± 2.4, n = 12; KV2.1 + KV6.4-Met419: k = 12.2 ± 1.2, n = 15; Kruskal-Wallis, P > 0.7), or in their 211 
time courses of recovery from inactivation (Figure S3G). These data suggest a loss of KV6.4 212 
function as a result of the p.Val419Met mutation. 213 
 214 
KV6.4-Met419 does not traffic with KV2.1 to the plasma membrane  215 
As discussed above, KV6.4 forms heterotetramers with KV2.1 with altered biophysical properties 216 
compared to homotetrameric KV2.1 channels (24) (Figure 1D-G, Figure S3). In addition, KV6.4 is 217 
retained in the endoplasmic reticulum in the absence of KV2.1, requiring the expression of KV2.1 218 
for trafficking to the cell membrane (25). We thus tested whether the p.Val419Met alteration might 219 
affect the trafficking of KV6.4. For this, KV6.4 was cloned into a pcDNA3 based vector containing 220 
a CMV-polioIRESmCherry expression cassette, tagged with HA and the p.Val419Met alteration 221 
introduced. KV2.1 had been previously cloned into the pCAGGS-IRES2-nucEGFP which displays 222 
nuclear GFP signal upon transfection. To assess membrane localisation, HEK293 cells were co-223 
transfected with both KV2.1 and KV6.4, stained for HA-tagged KV6.4, with co-expressing cells 224 
identified by both mCherry and nuclear GFP signal. KV6.4 was retained within the cytoplasm in 225 
the absence of KV2.1 expression but displayed a striking shift to the cell membrane upon co-226 
transfection with KV2.1 (Figure 2A). There was no appreciable difference in the localization of 227 
KV6.4-Met419 in the absence of KV2.1, but in the presence of KV2.1 and in contrast to the wild-228 
type protein, KV6.4-Met419 was retained intracellularly and showed no membrane localization 229 
(Figure 2A). Importantly, expression of KV6.4-Met419 in HEK293 cells showed only a modest 230 
reduction in steady-state stability compared with wild-type KV6.4, and this was not affected by co-231 
expression with KV2.1 (Figure 2B-C). 232 
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KV6.4 is expressed in nociceptors that innervate the uterus  233 
Altered KV function produces dramatic effects upon sensory neurone excitability; KV7 openers (26) 234 
and KV2 inhibitors (27) decrease and increase sensory neurone excitability respectively. We 235 
hypothesised that expression of KV6.4-Met419 within sensory neurones innervating the uterus 236 
would alter neuronal excitability and contribute to the impaired nociception. We first investigated 237 
the expression of Kcng4 and Kcnb1 in mouse uterine sensory neurones using single-cell qRT-PCR 238 
of sensory neurones retrogradely labelled with fast blue from the uterus (Figure 3A). Sensory 239 
innervation of the mouse uterus possesses two distinct peak densities within thoracolumbar (TL) 240 
and lumbosacral (LS) spinal segments (28). As such, fast blue-positive uterine sensory neurones 241 
were collected from dorsal root ganglia (DRG) isolated from vertebrae levels T12-L2 and L5-S2. 242 
These had an average cell diameter of 31.0 ± 0.7 µm (n = 89), which is in broad agreement with 243 
studies investigating sensory neurones innervating the uterus and other visceral organs including 244 
the distal colon (28, 29). Most uterine neurones expressed Kcnb1 (TL: 82% [36/44] and LS: 66% 245 
[30/45]) and Kcng4 mRNA was detected in a subset of uterine neurones from both spinal pathways 246 
(TL: 43% [19/44] and LS: 24% [11/45]; Figure 3B). The average cycle threshold (CT) value for 247 
Kcng4 expressing neurones was higher than that of Kcnb1 (27.2 vs. 16.3, Figure S4), which may 248 
indicate relative lower expression levels. Importantly, all but one LS neuron co-expressed Kcng4 249 
with Kcnb1, suggesting that these two KV subunits are predominantly present in the same uterine 250 
sensory neurone subset. We also assessed the mRNA expression of the nociceptor markers transient 251 
receptor potential vanilloid 1 (Trpv1) and voltage-gated sodium channel 1.8 (Scn10a). In Kcng4-252 
positive uterine sensory neurones Trpv1 mRNA was present in 100 % of TL and 91 % of LS 253 
neurones, and Scn10a in 95 % of TL and 91 % of LS neurones, suggesting that KV6.4 is expressed 254 
by a population of neurones capable of transducing noxious stimuli. (Figure 3B). 255 
 256 
  257 
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KV6.4–Met419 causes loss of modulatory function of KV2.1 and decreases 258 
neuronal excitability in DRG sensory neurones 259 
Given the high co-expression of Kcng4 with Kcnb1 in uterine sensory neurones, we next 260 
characterized the effect of KV6.4 and KV6.4–Met419 on sensory neuronal function. We recorded 261 
outward delayed rectifier K+ currents (IK) and investigated the effect of transient transfection of 262 
either KV6.4 or KV6.4-Met419 on the stromatoxin-1(ScTx)-sensitive IK; ScTx is a gating modifier 263 
of KV2.1, KV2.2 and KV4.2 which effectively blocks these channels (30), as well as KV2.1 264 
heterotetramers formed with silent KV subunits (31). Through subtraction of IK in the presence of 265 
ScTx from the total IK in the absence of ScTx, we isolated the ScTx-sensitive IK, which is 266 
predominantly dependent on KV2 channels (Figure 3C-F). A diverse and heterogenous population 267 
of KV2 and silent KV subunits is expressed in sensory neurones (29, 32, 33) and previous studies 268 
suggest that silent KV subunits only heterotetramerise with KV2 subunits and not KV1, KV3 and KV4 269 
subunits (24). As such, we predicted that wild-type KV6.4 heterotetramerisation with KV2.1 in 270 
sensory neurones would produce functional channels, but with a hyperpolarised shift in the voltage-271 
dependence of inactivation compared to homotetrameric KV2.1 channels, as we (Figure 1D-G) and 272 
others have observed previously in HEK293 cells (24). By contrast, we hypothesised that the KV6.4-273 
Met419 subunit would be unable to evoke such a hyperpolarising shift in the voltage-dependence 274 
of inactivation. 275 
By transfecting mouse sensory neurones with either KV6.4 or KV6.4-Met419, we attempted to bias 276 
available KV2.1 into heterotetramers with KV6.4 subunits, thus increasing the probability of 277 
recording the contribution of KV2.1/KV6.4 heterotetramers to ScTx-sensitive IK. In both KV6.4 and 278 
KV6.4-Met419 experiments, addition of ScTx led to a maximum reduction in the outward K+ current 279 
at a 20 mV step potential, which did not differ significantly (KV6.4, 52.7 ± 3.8 %; KV6.4-Met419, 280 
45.1 ± 7.7 %; Student’s t-test, P = 0.37; Figure 3C-E). The voltage-dependence of ScTx-sensitive 281 
IK activation was similar for neurones transfected with KV6.4 or KV6.4-Met419 subunit (V1/2 = −5.4 282 
± 1.8 mV vs. −9.8 ± 1.1 mV, and k = 8.6 ± 1.5 vs. 8.9 ± 0.9, respectively; Figure S5). As observed 283 
previously (33), the voltage-dependence of ScTx-sensitive IK inactivation, for both KV6.4 and 284 
KV6.4-Met419 experiments, was multifactorial and fitted with a sum of two Boltzmann functions. 285 
In neurones transfected with KV6.4, the midpoint of the first component was −0.8 ± 29.5 mV, which 286 
likely correlates with homotetrameric KV2.1 currents. The second component possessed a midpoint 287 
of inactivation of −60.2 ± 6.6 mV (n = 8); a current that is likely a function of heterotetrameric 288 
KV2/silent KV channels or differentially phosphorylated KV2 channels and in line with what others 289 
have reported for the second component of IK in DRG neurones in the presence of ScTx (33). 290 
Importantly, expression of KV6.4-Met419 led to a significant depolarising shift in the second 291 
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component of the voltage-dependence of inactivation (−33.8 ± 2.1 mV, n = 7, unpaired t-test, P = 292 
0.003, Figure 3F), whilst the first component, attributed to homotetrameric KV2.1 IK, remained 293 
unchanged (-36.2 ± 3.3 mV, unpaired t-test, P = 0.29, Table S4A). 294 
We assessed the functional consequences on neuronal excitability of such a shift in the availability 295 
of KV2 channels towards more depolarised potentials through current clamp experiments. The 296 
threshold for action potential discharge was assessed for neurones transfected with either KV6.4 or 297 
KV6.4-Met419, as well as neurones which exhibited no mCherry fluorescence from cultures 298 
exposed to either plasmid (considered untransfected). Neurones transfected with KV6.4-Met419 299 
exhibited a higher threshold, than those overexpressing KV6.4 or untransfected neurones during 300 
injection of a progressively depolarising current, (ramp protocol: 0-1 nA, 1s), however, only the 301 
difference between KV6.4-Met419 and KV6.4 reached statistical significance (KV6.4, 91.6 ± 16.7 302 
pA vs. KV6.4-Met419, 248.6 ± 50.3 pA, ANOVA with Bonferroni multiple comparisons P = 0.018; 303 
Untran., 112.5 ± 32.5 pA vs. KV6.4-Met419 248.6 ± 50.3 pA, P = 0.087; Figure 3G-H). A higher 304 
current was also required to evoke action potentials when threshold was assessed with a step 305 
protocol (+10 pA, 50 ms injections, starting at 0 pA). Similarly, only the difference between KV6.4 306 
and KV6.4-Met419 proved significant (KV6.4, 61.1 ± 12.2 pA vs. KV6.4-Met419, 172.0 ± 34.4 pA, 307 
ANOVA with Bonferroni multiple comparisons P = 0.012; Untran., 88.3 ± 13.8 pA vs. KV6.4-308 
Met419 172.0 ± 34.4 pA, P = 0.124; Figure 3I). The ability of neurones to respond to capsaicin was 309 
also examined to identify putative nociceptors (i.e. those expressing Trpv1), but no obvious pattern 310 
regarding the subpopulations of nociceptive and non-nociceptive neurones within each group could 311 
be observed. Analyses of other action potential parameters revealed no further differences between 312 
neurones transfected with either KV6.4 construct or untransfected cells (Table S4B). Taken 313 
together, these findings demonstrate that sensory neurones expressing KV6.4-Met419 are less 314 
excitable than those transfected with the KV6.4. We thus postulate that uterine primary afferent 315 
input into the pain pathway is likely to be reduced in women carrying the rare KCNG4 SNP 316 
rs140124801 allele.  317 
Heterozygous KV6.4-Met419 acts as a dominant negative mutation to abolish 318 
wild-type function. 319 
The SNP rs140124801 minor allele identified in those healthy women not requiring analgesia 320 
during their first labour was always in a heterozygote state. We asked if this heterozygous state has 321 
as much of an effect on KV2.1 as the homozygous state used in our sub-cellular localisation and 322 
electrophysiology studies, or if the effect size was in-between homozygous KV6.4 and homozygous 323 
KV6.4-Met419. Indeed, our findings of reduced labour pain are compatible with the minor allele of 324 
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rs140124801 having a dominant-negative effect, or a reduced dosage effect, but incompatible if 325 
acting as a recessive. KV2.1 was co-transfected into HEK293 cells with equimolar concentration of 326 
KV6.4 and KV6.4-Met419, stained for HA-KV6.4 and the membrane marker Na+/K+ ATPase. We 327 
found significant co-localisation of KV6.4 with Na+/K+ ATPase at the plasma membrane, but no 328 
evidence of trafficking to the cell membrane for either homozygote KV6.4-Met419, nor when KV6.4 329 
and KV6.4-Met419 were co-transfected (Figure 4A-B). 330 
Similarly, co-transfection of equimolar KV6.4 and KV6.4-Met419 with KV2.1 produces 331 
electrophysiological properties comparable to transfection of KV2.1 only, i.e. the co-expression of 332 
the minor allele variant prevented the hyperpolarising shift of the voltage-dependence of 333 
inactivation produced by the major allele variant (Figure 4C). 334 
In addition, we investigated whether KV6.4-Met419 might affect heterotetramerisation with KV2.1. 335 
Co-immunoprecipitation experiments in transfected HEK293 cells demonstrate that, unlike KV6.4, 336 
KV6.4-Met419 is unable to bind to KV2.1 (Figure S6). When KV6.4 is tagged but co-expressed with 337 
KV6.4-Met419 (untagged), there is notably reduced binding of KV6.4 to KV2.1 (Figure 5A). 338 
Similarly, by immunofluorescence analysis, the presence of untagged KV6.4-Met419 suffices to 339 
disrupt KV6.4 trafficking to the plasma membrane (Figure 5B and 5C). 340 
We therefore conclude that the KV6.4-Met419 variant acts as a dominant negative subunit and 341 
significantly affects the function of KV6.4 (and hence in turn KV2.1) in the heterozygote state 342 
identified in our cohort of women who did not require analgesia during their first labour. 343 
344 
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DISCUSSION  345 
Parturition may be physiological and widely considered to be ‘natural’ but remains amongst the 346 
most painful events in life that women can experience (34). Labour pain is a complex experience 347 
with many biopsychosocial determinants, of which visceral nociception is fundamental and 348 
necessary. Although the cellular and molecular substrates for visceral nociception are ill defined in 349 
humans, ion channels that are important regulators of uterine sensory neurone excitability, may 350 
determine visceral nociception and hence labour pain.  351 
Labour pain is challenging, if not impossible, to model adequately in pre-clinical laboratories. Our 352 
genetic approach in humans here was not to discover very rare Mendelian mutations that cause 353 
extreme and hence, pathological painlessness (e.g. Congenital Insensitivity to Pain). Instead, we 354 
sought to investigate SNPs that are more common, and for which frequencies in the general 355 
population are known. We hypothesised that such SNPs would be significantly over- or under-356 
presented in a cohort of women with a less extreme, but nonetheless clinically relevant phenotype. 357 
Hence, we chose to investigate healthy nulliparous women who chose and were able to manage 358 
pain from spontaneous and uncomplicated vaginal delivery of term labour without any analgesia. 359 
In this group, there were no deficits in detection of innocuous warmth, cool or cuff-grip pressure to 360 
suggest clinically relevant sensory neuropathy. There were also no differences in cognitive test 361 
battery performance, pain-relevant personality traits or emotional function, when compared to 362 
controls. However, these women demonstrate increased pain and tolerance thresholds to a range of 363 
noxious stimuli, and significantly so for cuff-pressure pain.  364 
Given that our painlessness phenotype is far less extreme compared to that of congenital 365 
insensitivity to pain, we did not expect that any rare-SNP(s) discovered in this study would cause a 366 
large increase in experimental pain threshold or tolerance for all stimulus modalities. Nonetheless, 367 
there is modest evidence from a study by Carvalho and colleagues that a composite of these 368 
measures obtained just before induction of labour in singleton, term pregnancies, predicts analgesic 369 
consumption, i.e. volume of local anaesthetic infused, in women who requested an epidural (35). 370 
The women recruited in the Carvalho cohort resembled the controls we employed in that they used 371 
analgesics during nulliparous labour. Our observation here that women who did not request any 372 
analgesic (epidural or Entonox) had an overall increase in experimental pain thresholds compared 373 
to controls is reassuringly consistent. However, the finding that cuff-pressure pain threshold was 374 
robustly and very significantly increased in those women is novel. Labour pain has visceral and 375 
somatic components, caused by contractions of uterine viscus, but also by sustained stretch or 376 
compression of pelvic floor, perineum and vagina (4), which occur in the later stages of labour as 377 
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the foetus descends, and may be experienced as a continuous background pain on which rhythmic 378 
pain caused by uterine contractions is superimposed (36). Whilst speculative, the hypothesis that 379 
women with high cuff-pressure pain thresholds would report reduced intensity of continuous 380 
background pain during labour is testable. 381 
Blinding was not feasible in our experiments and social desirability bias may explain our overall 382 
findings of increased threshold and tolerance of pain. However, such bias might be expected to also 383 
significantly lower scores for self-reported pain related traits, particularly pain catastrophizing (11), 384 
but that was not observed. Our data are consistent with those from other investigators who show 385 
that scores from Pain Catastrophizing Scale and Fear of Pain questionnaires do not influence self-386 
reported or behavioural measures of labour pain (37). Pain is a complex experience, with sensory-387 
discriminatory and affective-motivational aspects (38). We found that the test cohort had lower 388 
SFMPQ scores that pertained to the sensory, but not the affective qualities of the pain that was 389 
experienced during cold tolerance testing. In sum, we found increased threshold to pain from 390 
noxious stimuli (significantly so for cuff pressure), but no differences in cognitive, personality traits 391 
and emotional function, in women who did not require analgesics during term nulliparous labour. 392 
These findings suggest that nociceptive function is altered in these women and validate their 393 
selection to discover predisposing genetic changes in sensory neurones (nociceptors) that might 394 
influence labour pain in women: a phenotype that otherwise would confidently have been expected 395 
to be highly heterogeneous. 396 
We detected a single SNP, rs140124801 in the gene KCNG4 where the rare allele had a significant 397 
over-representation when compared to the general population in a cohort of 158 women who had 398 
no analgesic requirement during nulliparous labour, noting that ideally control allele frequencies 399 
would have been generated from a matched cohort of women who did require analgesia. There were 400 
4 heterozygotes who possess the rare allele, and data on quantitative sensory and pain testing were 401 
available for 3 heterozygotes. We found that women who possess the rare allele showed a 402 
significantly increased cuff-pressure pain threshold, when compared to controls (Supplemental 403 
materials; Table S3). The rare allele of SNP rs140124801 causes a mis-sense change p.Val419Met 404 
in KV6.4, a silent KV subunit that forms heterotetramers with KV2 channels and modulates their 405 
function (23). We, and others, show that KV6.4 traffics to the plasma membrane only when co-406 
expressed with KV2.1 (25). In contrast, we found that the rare allele product KV6.4-Met419 failed 407 
to traffic to the plasma membrane when co-expressed with KV2.1. Moreover, KV6.4-Met419 failed 408 
to induce the hyperpolarising shift in the voltage-dependence of KV2.1 inactivation that is observed 409 
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with KV6.4, likely indicating that the observed currents would be conducted by KV2.1 410 
homotetrameric channels. 411 
We have found that KV6.4-Met419 was unable to heterotetramerise with KV2.1. A possible 412 
explanation for this is gained from X-ray crystallography of KV2.1 homotetramer (RCSB Protein 413 
Data Bank ID: 3LNM; and see Supplemental data). Each of the four KV2.1 monomers contributes 414 
equally to the K+ ion selectivity region, which is formed by the peptide backbone carbonyl groups 415 
of the amino acids TVGYG. The side chains of Valine and Tyrosine from each of the four 416 
monomers fits within an aliphatic pocket of the adjacent monomer (composed of amino acids 417 
WWAIIS, see Figure 1C). The rare allele of SNP, rs140124801 results in Valine being changed to 418 
Methionine, the side chain of which is too large to be accommodated by this aliphatic pocket. This 419 
may be sufficient to stop KV6.4 forming a heterotetramer with KV2.1 and would be predicted to 420 
disrupt the close packing of the peptide backbone carbonyl groups of the ion selectivity region. 421 
For KV6.4 to modulate labour pain it needs to be expressed in an appropriate part of the sensory 422 
nervous system. We focused on uterine sensory neurones, but this does not negate the possibility 423 
that KV6.4 also exerts influence elsewhere in the nervous system, KCNG4 mRNA also being 424 
expressed in regions of the spinal cord and brain (Figure S7). We observed KV6.4 expression in 425 
Trpv1 and NaV1.8-positive mouse uterine sensory neurones, consistent with the observation that 426 
sensory neurones innervating deep tissues display comparatively high Trpv1 expression (39). 427 
Results from unbiased single-cell RNA-sequencing of mouse DRG obtained from cervical to 428 
lumbar levels reveal no specific coexpression of KV6.4 in nociceptive Trpv1/Scn10a expressing 429 
neurones (32). However, single-cell RNA-sequencing of colonic sensory neurones identified that 430 
KV6.4 does co-localise with Trpv1 and NaV1.8 (29), consistent with our findings here that KV6.4, 431 
Trpv1 and NaV1.8 are coexpressed in uterine sensory neurones from T12-L2 and L5-S2 DRG. 432 
Taken together, these data suggest that KV6.4 might be a marker for sensory neurones that innervate 433 
the viscera. Due to the restricted expression of Kcng4 in a particular sensory neurone type, 434 
expression of KV6.4-Met419 is expected to reduce excitability specifically for this class of sensory 435 
neurones.  436 
For the rare allele rs140124801 to modulate labour pain it needs to cause a significant change in 437 
KV6.4-influenced neuronal activity, and to do so in the heterozygote state. Our electrophysiology 438 
and cell trafficking studies showed that the mutant KV6.4-Met419, as opposed to KV6.4, had no 439 
effect on KV2.1 function, nor was it trafficked to the plasma membrane. Transfection of KV6.4 into 440 
mouse sensory neurones produced a more hyperpolarised voltage-dependence of inactivation for 441 
the predicted heterotetrameric KV2/silent KV channel component of IK than when KV6.4-Met419 442 
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was transfected, further supporting the hypothesis that the loss-of-function KV6.4-Met419 results 443 
in more KV2.1 activity at positive voltages. KV2.1 is known to contribute to the after-444 
hyperpolarisation duration, intra-action potential refractory period, and thus regulate neuronal 445 
excitability (27). Hence, we anticipated that a KV6.4-Met419-induced deficit in KV2.1 function 446 
would likely result in fewer action potentials and thus less pain during periods of sustained 447 
nociceptor activity, such as that occurring with uterine contractions during labour. Although we did 448 
not observe a difference in the after-hyperpolarisation duration or action potential frequency 449 
between sensory neurones transfected with KV6.4 or KV6.4-Met419 (possibly due to the continual 450 
current injection used), we did find that a larger amount of current was required to cause KV6.4-451 
Met419 expressing neurones to fire actions potentials and thus conclude that the mutation confers 452 
reduced neuronal excitability. Critically, we observed that KV6.4-Met419 has a dominant negative 453 
effect on KV6.4, regarding modulation of the voltage-dependence of inactivation for KV2.1. This 454 
result likely explains the reduction in labour pain seen in individuals in our cohort who were 455 
heterozygotes for the SNP rs140124801 rare allele. 456 
There is a growing understanding of the distinctions between the neural pathways for pain from 457 
visceral and somatic tissues: each have evolved nociceptors that sense damage in different physical 458 
environments (40). Our findings suggest a key role for KV6.4 in specifically regulating nociceptor 459 
excitability, and hence pain, in normal labour. Kv6.4 is also expressed in other parts of the nervous 460 
system (Figure S7) and its expression in non-neural tissues is unknown. However, we found that 461 
women carrying the rare allele KCNG4 managed nulliparous labour without analgesics, have higher 462 
experimental pain thresholds but are otherwise healthy without any psychological or cognitive 463 
abnormalities. Their phenotype suggests that the loss of modulatory effects of KV6.4 is non- 464 
pathogenic in other parts of the nervous system and non-neural tissues. If druggable, Kv6.4 would 465 
be a potential target for modulating labour pain without the maternal and neonatal side effects 466 
inherent in other analgesic interventions in this setting. Our data also raise the question of whether 467 
KV6.4 has roles in other painful visceral disorders, both within and outside the female genital tract. 468 
One closely related context would be primary dysmenorrhea, which is characterised by severe pain 469 
associated with uterine contraction during menstruation (41). Further development of selective 470 
KV6.4 pharmacological agents is required to fully probe the role of KV6.4 in visceral pain. 471 
  472 
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MATERIALS AND METHODS 473 
For detailed Materials and Methods, see Supplementary Materials 474 
Study Design 475 
The purpose of this study was to identify possible genetic contributions affecting the levels of pain 476 
experienced by women during their first labour. We screened >1000 cases and ascertained a cohort 477 
of 189 healthy women who had given birth without any use or request for analgesics. A DNA 478 
sample was collected from each (158 provided DNA samples of sufficient quality for further 479 
analysis). 39 of this cohort consented for comprehensive psychometric and quantitative sensory 480 
testing (QST) and were compared to 33 matched controls who used analgesics during labour and 481 
delivery of their firstborn. Psychometric evaluation focused on emotional function, cognitive 482 
abilities and personality traits that may influence the experience of pain. QST comprised 483 
ascertaining somatic sensory detection, pain and tolerance thresholds of thermal and mechanical 484 
stimuli in controlled experimental settings. 485 
The chronologically first 100 DNA samples collected were designated a discovery cohort and 486 
underwent full exome sequencing. We mined the data for rare allele SNPs that were statistically 487 
under or over represented (by Chi-squared test with two tails and Yates correction) in the discovery 488 
cohort after false discovery rate (FDR) correction and identified a p.Val419Met alteration in 489 
KCNG4, which was then sequenced by Sanger Sequencing methodology in the 58 women 490 
replication cohort. This data led us to investigate the potential contribution of the KCNG4 encoded 491 
protein KV6.4 to the phenotype observed.  492 
KV6.4 was cloned, tagged and the p.Val419Met introduced by site-directed-mutagenesis with 493 
pathogenicity assessed by electrophysiological characterization and assessment of intracellular 494 
localization in HEK293 cells. The finding of the alteration behaving as a dominant negative, loss 495 
of function mutation led us to investigate the physiological role of KV6.4 in uterine sensory 496 
neurones. Using retrograde labelling we identified uterine sensory neurones (89 were collected) and 497 
performed single-cell qRT-PCR to identify KV6.4 expression alongside binding partner KV2.1 and 498 
nociceptor marker genes. Finally, having identified KV6.4 expression alongside KV2.1 in a 499 
significant proportion of uterine sensory neurones, we further characterized the effects of 500 
expressing the KV6.4 minor allele in mouse sensory neurones by whole-cell patch-clamp recording, 501 
confirming our initial findings of KV6.4 Met419 as a loss of function mutation and demonstrating 502 
decreased excitability of neurones transfected with KV6.4-Met419. 503 
  504 
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Statistical Analyses 505 
For psychometric and quantitative sensory testing, statistical analyses were performed with R 506 
Studio (Version 1.1.442). The mean and standard deviation were generated for each outcome 507 
variable for test and control cohorts. Shapiro-Wilk tests and F-tests were used assess data normality 508 
and differences in variances. Differences between the means of each outcome variable in test and 509 
control cohorts were assessed using tests for two independent samples, using Student’s t-test, 510 
Welch’s t-test or Mann-Whitney U tests when the relevant assumptions were met. The level of 511 
statistical significance was adjusted using Sidak’s correction. The correction applied to multiple 512 
outcomes associated with each domain of assessments: questionnaires, CANTAB, sensory 513 
detection, pain thresholds and tolerance.  514 
For statistical assessment of the genetic data collected in this study, enrichment of amino acid 515 
altering SNPs was assessed by exome sequencing, with exome vcf, bam and bam.bai files 516 
iteratively analyzed to extract data on all SNPs in or near to exons, including the depth and quality 517 
of the sequence data, and the alleles detected (9). For each SNP the allele frequencies were 518 
compared to normal values derived from the 1000 genomes project and exome variant server, and 519 
deviations assessed for significance using a Chi-squared test with two tails and Yates correction. 520 
The resulting P values were subject separately to a Bonferroni and FDR correction, as 521 
approximately 100,000 SNPs were assessed in our fSNPd method. 522 
We then focused only on ion channels, defined as being identified by the Gene Ontology Term 523 
GO:0005216 (423 genes, which were also hand curated and checked against a Pfizer/Neusentis 524 
database that had been shared with us). There were 28 SNPs found in ion channels and each was in 525 
a different gene; there was only one detected SNP in KCNG4. Eight of these SNPs were then 526 
eliminated because the protein change caused by the rare allele was common in the orthologous 527 
mammalian proteins. For the remaining 20 SNPs, we determined the allele frequency of each of the 528 
by use of the Integrated Genome Viewer examining the cohort’s exome bam files individually. This 529 
led to the elimination of 19 SNPs, 14 as the common allele frequency was 100% and program errors 530 
in assigning alleles within our discovery cohort had falsely appeared to show a deviation from 531 
100%, and five because of misalignment of reads to homologous genes leading to errors in SNP 532 
allele calling and SNP allele frequency calculation. 533 
Further statistical tests used to assess differences between KV6.4 and KV6.4-Met419 throughout the 534 
study are unpaired t-tests and ANOVA with Bonferroni’s multiple comparison post-hoc test, as 535 
described in the relevant figure legends and Supplementary Methods. Differences between groups 536 
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were considered significant at a P value < 0.05, and were tested using GraphPad (Prism5.0, 537 
California, USA). 538 
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  566 
Main Figures and Tables 567 
 568 
 569 
Table 1 Key characteristics of test cohort comprising women who did not request or require analgesics during 570 
nulliparous term spontaneous labour and controls who did. n, number of participants; SD, standard deviation; * 571 
Sidak’s correction; CI5-CI95, 5-95% confidence interval; # missing clinical record; ## equipment failure or 572 
unavailable; SFMPQ, short-form McGill’s Pain Questionnaire. 573 
  574 
Characteristics
(at delivery of first-born)
Test cohort Control cohort P 
unadjusted
P 
adjusted * CI5 CI95n mean SD n mean SD
Age  (years) 39 32.83 4.18 33 31.94 3.98 0.33 -2.73 0.93
Head circumference of newborn (cm) #26 34.00 0.98 +24 34.46 0.97 0.10 -0.10 1.01
Weight of newborn (g) 38 3362 434.1 33 3384 419.2 0.83 -180.90 224.76
Characteristics 
(at research visit)
Test cohort Control cohort P 
unadjusted
P 
adjusted * CI5 CI95n mean SD n mean SD
Age  (years) 39 36.26 4.18 33 36.45 4.11 0.62 -1.48 2.46
Upper arm diameter at assessment (cm) 39 28.54 3.60 33 29.23 3.63 0.43 -1.03 2.41
Sensory and pain thresholds
Cold detection (°C) 39 30.45 0.93 33 30.35 0.95 0.79 -0.42 0.25
Warm detection (°C) 39 34.43 0.99 33 34.97 0.87 0.002 0.012 0.28 1.05
Cuff pressure detection (mmHg) 39 28.44 7.79 33 27.10 8.38 0.51 -5.00 1.33
Cold pain (°C) 39 11.64 8.26 33 16.88 9.03 0.02 0.114 1.17 9.73
Heat pain (°C) 39 44.08 2.85 33 42.36 3.40 0.018 0.103 -2.92 -0.27
Cuff pressure pain (mmHg) 39 166.7 54.74 33 113.03 42.96 0.00002 0.00012 -77.03 -30.13
Pain tolerance (cold immersion)
Pre-immersion hand temperature (°C) 34 30.46 1.95 33 30.82 1.66 0.42 -0.53 1.24
Post-immersion hand temperature (°C) ##33 17.92 4.72 33 20.51 3.54 0.02 0.12 0.40 4.60
Latency to hand withdrawal (s) ##36 77.03 71.82 33 44.11 55.73 0.03 0.14 -38.0 -0.0000
Peak pain occurrence (0-100mm) ##35 80.19 27.39 33 79.04 28.99 0.71 -5.50 4.00
Peak pain intensity (0-100mm) ##35 54.29 17.26 33 65.82 13.20 0.004 0.02 3.20 18.1
SFMPQ (sensory) 36 8.47 3.82 33 10.97 4.00 0.010 0.049 0.62 4.38
SFMPQ (affective) 36 1.00 1.53 33 1.24 1.35 0.26 -0.00002 0.99995
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 575 
Figure 1 Molecular genetics of KCNG4 SNP rs140124801, and analysis of KV2.1 inactivation properties (A) 576 
Summary of the genetic analysis. The resultant finding is of the SNP rs140124801 in KCNG4. Inset: 577 
electrophoretograms showing the alleles. (B) The nucleotide sequence of the SNP rs140124801 578 
(NM_1.NM_172347.2) showing the altered GTG codon (in bold), and the rare allele (in red). Amino acids 416 to 423 579 
of KV6.4 (NP_758857.1) are shown below their nucleotide codons. The selectivity filter is in bold, and the wild type 580 
Val-419 shown above Met-419. (C) Evolutionary conservation of human KV6.4 positions 408 to 426: rs140124801 581 
alleles, representative proteins of each human KV class, and of KV6.4 in vertebrates. Invariant amino acids are 582 
capitalized. The selectivity filter TVGYG in yellow, and conserved aliphatic region in grey. Representative current 583 
recordings to determine KV2.1 (D), KV2.1/KV6.4 (E), KV2.1/KV6.4-Met419 (F) steady-state inactivation properties. 584 
The applied voltage protocol is illustrated above (D). Vertical scale bar is 10 nA, horizontal scale bar is 0.5 s. Green 585 
traces indicate currents recorded during the −40 mV conditioning step. (G) Voltage-dependence of steady-state 586 
inactivation of KV2.1 (grey filled circles, n = 9), KV2.1/KV6.4 (white squares, n = 12), and KV2.1/KV6.4-Met419 587 
(black squares, n = 15). Solid lines represent the Boltzmann fitted curves. 588 
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 590 
Figure 2 p.Val419Met blocks KV6.4 from reaching the plasma membrane independent of changes in steady-state 591 
expression (A) Immunofluorescence analysis of KV6.4 localization. In the absence of KV2.1, KV6.4 was retained in 592 
the cytoplasm (white channel, top panel), and was trafficked to the cell membrane in the presence of KV2.1 (white 593 
channel, 2nd panel down, white arrow). In contrast, HA-tagged KV6.4-Met419 did not localize to the cell membrane 594 
in either the absence or presence of KV2.1 expression (white channels in the 3rd and 4th panel down, white arrow). 595 
Expression of KV2.1 is demonstrated by presence or absence of green nuclei, expression of KV6.4 is displayed 596 
directly by HA tag in the white channel and expression of the IRES vector expressing KV6.4 is displayed by presence 597 
of mCherry signal in the red channel. Graphs adjacent to each panel display the intensity of KV6.4 HA signal along 598 
the red line in each respective white channel; note membrane localized peaks only in KV6.4 when co-expressed with 599 
KV2.1. Scale bars indicate 10 µm (B) HA-tagged KV6.4 was transiently expressed in the presence or absence of 600 
KV2.1. There was a modest reduction in steady state stability for KV6.4-Met419 compared with KV6.4. (C) Stability 601 
assessed by densitometry of HA compared with mCherry as a control of transfection efficiency. Unpaired t-test (P = 602 
0.04). 603 
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 605 
Figure 3 Kcng4 is coexpressed with Kcnb1 in mouse uterine sensory neurones and expression of KV6.4-Met419 in 606 
mouse sensory neurones increases the threshold for action potential discharge, compared to KV6.4 (A) Uterine 607 
sensory neurones were retrogradely labelled using fast blue and harvested following dissociation. (B) Co-expression 608 
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analysis of thoracolumbar (T12-L2) and lumbosacral (L5-S2) uterine sensory neurones expressing transcripts for 609 
Kcng4, Kcnb1, Trpv1 and Scn10a. Each segment in the wheel-diagram is representative of a single cell, with a 610 
coloured segment signifying positive expression. (C) Representative current recordings to determine the voltage 611 
dependence of steady-state inactivation of the stromatoxin-1 (ScTx)-sensitive IK elicited by the inset voltage protocol 612 
in the absence (C) and presence (D) of 100nM ScTx. Green traces indicate currents recorded during the −40 mV 613 
conditioning step. (E) The ScTx-sensitive IK was obtained by subtraction of D from C. (F) Inactivation curves for the 614 
ScTx-sensitive IK for neurones transfected with either KV6.4 or KV6.4-Met419. Both datasets were fit with a sum of 615 
two Boltzmann functions. The midpoints of both the 2nd components of these fits are plotted as either light dashed 616 
(KV6.4) or heavy dashed (KV6.4-Met419) lines. (G) Representative current clamp recordings of neurones of 617 
comparable capacitance transfected with either KV6.4 or KV6.4-Met419 showing action potentials evoked by ramp 618 
injection of current (0-1 nA, 1s). The thresholds for action potential discharge are annotated with light dashed (KV6.4) 619 
or heavy dashed (KV6.4-Met419) lines. Summary data of action potential thresholds obtained from neurones 620 
transfected with either KV6.4 or KV6.4-Met419 and untransfected controls obtained via a (H) ramp protocol (0-1 nA, 621 
1s) or (I) step protocol (+10 pA, 50 ms). Red points represent cells that responded to 1 µM capsaicin in voltage clamp 622 
mode. Both recordings in Panel G were from cells which were capsaicin responders. Bars indicate mean values, error 623 
bars indicate SEM, n = 6-10, * P < 0.05, one-way ANOVA with Bonferroni’s correction for multiple tests. 624 
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Figure 4 Sub-cellular localization and electrophysiology analysis of the dominant-negative effect of human KV6.4-628 
Met419 (A) HEK293 and HeLa cells (separate experiments) were transfected with KV2.1 and either wild-type KV6.4, 629 
KV6.4-Met419 or equimolar concentrations of KV6.4/KV6.4-Met419. Cell membranes were stained with Na+/K+ 630 
ATPase (red channel) and HA-tagged KV6.4 (green channel). HA-tagged KV6.4 localized to the cell membrane, 631 
showing significant co-localization with Na+/K+ ATPase. Both KV6.4-Met419 and KV6.4/KV6.4-Met419 co-632 
expression showed cytoplasmic retention of KV6.4 and no evidence of co-localization with Na+/K+ ATPase. Graphs 633 
below each pane display the profile of signal for membrane and KV6.4.HA along the plane of the white line in the 634 
merged image. Note red and green signal co-localise in the KV6.4 experiment and are distinct in the KV6.4-Met419 635 
and heterozygote experiment. (B) Quantification of Pearson’s co-localization co-efficient between KV6.4.HA and 636 
Na+/K+ ATPase in each experimental condition. For each condition at least 17 cells were counted from three 637 
independent experiments. (C) Voltage of half-maximal inactivation from inactivation protocols shown in Figure 1D-638 
G. Co-expression of both KV6.4 and KV6.4-Met419 with KV2.1 failed to evoke a shift in the voltage-dependence of 639 
inactivation. Bars indicate mean values, error bars indicate SEM, n = 9-15, *** P < 0.001. Statistics in B and C 640 
represent one-way ANOVA with Bonferroni’s multiple comparisons test. 641 
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Figure 5 Effects of KV6.4-Met419 on KV2.1 heterotetramerisation. (A) Wild Type KV6.4 co-immunoprecipitates 645 
with KV2.1 when co-expressed in HEK293 cells (pulling down with KV2.1 or HA-tagged KV6.4). KV6.4-Met419 646 
disrupts binding to KV2.1, and there is significantly reduced binding of HA-tagged KV6.4 to KV2.1 when co-647 
expressed with untagged KV6.4-Met419. B KV6.4 traffics to the plasma membrane less efficiently when co-expressed 648 
with untagged KV6.4-Met419, indicating a dominant negative effect. (C) Quantification of KV6.4 membrane 649 
localization by Pearson’s coefficient assessing colocalisation of HA and Na+/K+ ATPase membrane marker, data 650 
from three independent experiments. 651 
652 
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